-
RCP survey finds over 1 in 4 doctors sought mental health support during pandemic
pharmatimes
January 22, 2021
A new survey from the Royal College of Physicians (RCP) has found that almost a fifth of its members had sought informal mental health support during the COVID-19 pandemic.
-
Bamlanivimab Reduced Risk of COVID-19 at Nursing Homes in Phase 3 Trial
americanpharmaceuticalreview
January 22, 2021
Bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, Eli Lilly and Company announced.
-
Adamis submits IND application to FDA for Covid-19 treatment
pharmaceutical-technology
January 22, 2021
Speciality biopharmaceutical company Adamis Pharmaceuticals has submitted an Investigational New Drug (IND) to the US Food and Drug Administration (FDA) for the use of Tempol to treat Covid-19.
-
COVID-19 has multiple faces
worldpharmanews
January 21, 2021
According to current studies, the COVID-19 disease which is caused by the SARS-CoV-2 coronavirus comprises at least five different variants.
-
Israel set to be first country to vaccinate entire population against COVID-19
europeanpharmaceuticalreview
January 21, 2021
A new report has said that Israel is expected to be the first country in the world to vaccinate its population against COVID-19.
-
UK vaccine supply chain workers to be offered COVID-19 jabs
europeanpharmaceuticalreview
January 21, 2021
Around 2,000 workers critical to the UK COVID-19 vaccine supply chain will be offered inoculations against the novel coronavirus.
-
Blood test can identify COVID-19 patients at high risk of life-threatening complications
europeanpharmaceuticalreview
January 21, 2021
The rapid blood test could be used to identify hospitalised COVID-19 patients who may benefit from investigational treatments and early interventions.
-
CoVerified Announces Partnership with Mirimus for Nationwide K-12 Pooled Saliva COVID-19 Testing Program
prnewswire
January 21, 2021
?CoVerified, a leading provider of custom software platforms and COVID-19 testing for colleges and universities, announced its program to bring COVID-19 testing and an education-focused software platform to K-12 schools across the nation.
-
CDSCO’s expert panel recommends approval for phase 1 trial of Bharat Biotech’s nasal vaccine for COVID-19
expresspharma
January 21, 2021
An intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes.
-
AHF calls on govts, public health leaders to decentralise efforts to tackle COVID-19
expresspharma
January 21, 2021
Tap into resources that have so far been discounted, particularly civil society and all organisations with close community ties, says AHF.